Rafael Holdings, Inc. Class B Common Stock
Symbol: RFL (NYSE)
Company Description:
Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $1.33
- Yesterday High: $1.51
- Yesterday Low: $1.32
- Yesterday Volume: 121.24K
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
- Name: Rafael Holdings, Inc. Class B Common Stock
- Website: https://www.rafaelholdings.com
- Listed Date: 2018-03-06
- Location: NEWARK, NJ
- Market Status: Active
- CIK Number: 0001713863
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $46.69M
- Round Lot: 100
- Outstanding Shares: 35.10M
- Asset Type: CS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-05 | 4 | View |
| 2025-08-11 | 3 | View |
| 2025-08-07 | 8-K | View |
| 2025-07-22 | 3 | View |
| 2025-07-18 | 8-K | View |
| 2025-06-26 | S-8 | View |
| 2025-06-24 | 4 | View |
| 2025-06-18 | 8-K | View |
| 2025-06-17 | 4 | View |
| 2025-06-11 | 10-Q | View |
| 2025-06-11 | 8-K | View |
| 2025-06-09 | SCHEDULE 13D/A | View |
| 2025-06-09 | SCHEDULE 13D/A | View |
| 2025-06-09 | 4 | View |
| 2025-06-04 | 8-K | View |
| 2025-05-30 | 4 | View |
| 2025-05-29 | 4 | View |
| 2025-05-20 | 8-K/A | View |
| 2025-05-06 | 8-K | View |
| 2025-05-06 | 424B3 | View |